Finance

Lists
Outlook: 53.8% bullish·3.9% bearish
Go to analysis
LYB:NYSE
Lyondellbasell Industries N.v
$60.72
-1.48%
(-0.91) 1D
$60.72
0.00% (0.00)
After hours
Closed: Nov 6, 4:00:05 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LYB...
Open
$61.13
High
$62.00
Low
$60.64
Mkt. cap
19.63B
Avg. vol.
3.64M
Volume
3.07M
Dividend
4.55%
Quarterly dividend
$0.69
Ex-dividend date
Aug 24, 2026
P/E ratio
15.27
52-wk high
$83.94
52-wk low
$41.58
EPS
$3.98
Beta
0.24
Shares outstanding
323.24M
No. of employees
19K
Open
$61.13
High
$62.00
Low
$60.64
Mkt. cap
19.63B
Avg. vol.
3.64M
Volume
3.07M
Dividend
4.55%
Quarterly dividend
$0.69
Ex-dividend date
Aug 24, 2026
P/E ratio
15.27
52-wk high
$83.94
52-wk low
$41.58
EPS
$3.98
Beta
0.24
Shares outstanding
323.24M
No. of employees
19K
News stories
From web sources and news partners
Profile
LyondellBasell Industries N.V. is an American multinational chemical company, incorporated in the Netherlands with U.S. operations headquartered in Houston, Texas and offices in London, UK. The company is the largest licensor of polyethylene and polypropylene technologies. It also produces ethylene, propylene, polyolefins, and oxyfuels. LyondellBasell was formed in December 2007 by the acquisition of Lyondell Chemical Company by Basell Polyolefins for $12.7 billion. As of 2016, Lyondell was the third largest independent chemical manufacturer in the United States. LyondellBasell's global headquarters is located in Williams Tower in Houston, Texas. Wikipedia
About Lyondellbasell Industries N.v
CEOPeter Vanacker
Employees19K
FoundedDec 2007
HeadquartersRotterdam, South Holland, Netherlands
SectorMaterials
IndustryCommodity chemical
Websitelyondellbasell.com
Analyst ratings
Based on 12 analysts giving stock ratings to LYB in the past 3 months
Hold
Buy
4
Hold
6
Sell
2
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for LYB in the last 3 months.
Highest
Current $60.72
$82.00 (+35.05%)
Average
$72.45 (+19.32%)
Lowest
$66.00 (+8.70%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vincent Andrews
Morgan Stanley
Buy
Reiterated
$72.00
+18.6%
11/03/2026
Joshua Spector
UBS
Hold
Reiterated
$69.00
+13.6%
11/03/2026
Patrick Cunningham
Citi
Hold
Maintained
$74.00
+21.9%
11/03/2026
Jeffrey Zekauskas
J.P. Morgan
Buy
Maintained
$80.00
+31.8%
11/02/2026
Duffy Fischer
Goldman Sachs
Sell
Maintained
$69.00
+13.6%
11/01/2026
John McNulty
BMO Capital
Hold
Reiterated
$72.00
+18.6%
11/02/2026
Arun Viswanathan
RBC Capital
Buy
Maintained
$82.00
+35%
11/02/2026
John Roberts CFA
Mizuho Securities
Hold
Maintained
$68.00
+12%
11/02/2026
Matthew DeYoe
Bank of America Securities
Sell
Reiterated
$66.00
+8.7%
11/02/2026
Abigail Eberts
Wells Fargo
Buy
Maintained
$76.00
+25.2%
11/01/2026
Aleksey Yefremov
Barclays
Hold
Maintained
$69.00
+13.6%
11/02/2026
Michael Leithead
Barclays
Hold
Initiated
$66.00
+8.7%
10/12/2026
Unknown Analyst
KeyBanc
Hold
Initiated
-
-
09/11/2026
Salvator Tiano
KeyBanc
Hold
Initiated
-
-
09/11/2026
Michael Sison
Wells Fargo
Buy
Reiterated
$70.00
+15.3%
07/02/2026
Hassan Ahmed
Alembic Global
Buy
Reiterated
$83.00
+36.7%
07/02/2026
Unknown Analyst
Argus Research
Hold
Maintained
-
-
05/18/2026
David Begleiter
Deutsche Bank
Hold
Reiterated
$80.00
+31.8%
05/05/2026
Eric Boyes
Evercore ISI
Hold
Maintained
$70.00
+15.3%
05/04/2026
Laurence Alexander
Jefferies
Hold
Maintained
$70.00
+15.3%
03/10/2026
Frank Mitsch
Fermium Research
Buy
Upgraded
$74.00
+21.9%
03/09/2026
Kevin McCarthy
Vertical Research
Buy
Upgraded
$75.00
+23.5%
03/09/2026
Last report
Oct 30, 2026
Fiscal period
Q3 2026
$2.54 / $2.55
-0.41%miss
Revenue / Est. (USD)
8.50B / 8.89B
-4.38%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
7.09B
7.20B
9.18B
8.50B
Cost of goods sold
6.75B
6.50B
7.11B
6.93B
Cost of revenue
6.75B
6.50B
7.11B
6.93B
Research and development expenses
33.00M
36.00M
34.00M
35.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
376.00M
415.00M
390.00M
398.00M
Operating expense
409.00M
451.00M
424.00M
433.00M
Total operating expenses
7.16B
6.95B
7.53B
7.36B
Operating income
-65.00M
250.00M
1.64B
1.14B
Other non operating income
-21.00M
10.00M
61.00M
15.00M
EBT including unusual items
-144.00M
135.00M
807.00M
961.00M
EBT excluding unusual items
-118.00M
150.00M
1.65B
1.04B
Income tax expense
-8.00M
-2.00M
236.00M
187.00M
Effective tax rate
5.56%
-1.48%
29.24%
19.46%
Other operating expenses
-
-
-
-
Net income
-142.00M
123.00M
558.00M
756.00M
Net profit margin
-2.00%
1.71%
6.08%
8.90%
Earnings per share
-0.26
0.49
4.30
2.54
Interest and investment income
25.00M
31.00M
24.00M
29.00M
Interest expense
-134.00M
-140.00M
-139.00M
-140.00M
Net interest expenses
-109.00M
-109.00M
-115.00M
-111.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
167.00M
592.00M
1.99B
1.51B
Gain or loss from assets sale
-112.00M
-
734.00M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps